TEXAS VIRTUAL MPN WORKSHOP: Module VI

Novel Pathways and Targets in MPNs: Moving Beyond JAKi

Presentations
Myeloproliferative Neoplasms: Context, Pathways and Targets
Alison Moliterno, MD, Johns Hopkins Medicine, Baltimore, MD
28 August, 2020
Targeted Therapies in Combination with JAK Inhibitor
Lucia Masarova, MD, UT MD Anderson Cancer Center, Houston, TX
28 August, 2020
Novel Targeted Therapies Beyond JAK Inhibitors
Naveen Pemmaraju, MD, UT MD Anderson Cancer Center, Houston, TX
28 August, 2020

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter